Not Rated
Fund Size
(1.6% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
---|---|---|---|---|---|---|
1 Week | 13-Oct-25 | 10077.00 | 0.77% | - | 1.32% | 181/238 |
1 Month | 19-Sep-25 | 9869.30 | -1.31% | - | 0.15% | 194/235 |
3 Month | 18-Jul-25 | 9885.50 | -1.15% | - | 2.09% | 202/230 |
6 Month | 17-Apr-25 | 10608.80 | 6.09% | - | 11.04% | 199/224 |
YTD | 01-Jan-25 | 9765.30 | -2.35% | - | 4.10% | 170/212 |
1 Year | 18-Oct-24 | 9883.10 | -1.17% | -1.16% | 0.39% | 112/195 |
2 Year | 20-Oct-23 | 14899.20 | 48.99% | 22.03% | 19.61% | 50/152 |
3 Year | 20-Oct-22 | 18262.80 | 82.63% | 22.21% | 19.71% | 38/127 |
5 Year | 20-Oct-20 | 22712.60 | 127.13% | 17.82% | 22.35% | 75/103 |
10 Year | 20-Oct-15 | 33109.60 | 231.10% | 12.71% | 14.05% | 55/76 |
Since Inception | 05-Jun-04 | 516948.60 | 5069.49% | 20.26% | 12.86% | 35/217 |
Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
---|---|---|---|---|---|
1 Year | 18-Oct-24 | 12000 | 12324.78 | 2.71 % | 5.04 % |
2 Year | 20-Oct-23 | 24000 | 27005.55 | 12.52 % | 11.78 % |
3 Year | 20-Oct-22 | 36000 | 48048.77 | 33.47 % | 19.65 % |
5 Year | 20-Oct-20 | 60000 | 93396.59 | 55.66 % | 17.73 % |
10 Year | 20-Oct-15 | 120000 | 306834.53 | 155.7 % | 17.85 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
---|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 9974.5 | 12.29% | 0.35% | 14.01% (Jan 2025) | 11.94% (Aug 2025) | 62.56 L | 0.00 |
Lupin Ltd. | Pharmaceuticals | 5894.4 | 7.26% | 1.17% | 8.47% (Dec 2024) | 5.82% (May 2025) | 30.84 L | 4.00 L |
Divis Laboratories Ltd. | Pharmaceuticals | 5689.7 | 7.01% | -0.33% | 9.65% (Nov 2024) | 7.01% (Sep 2025) | 10.00 L | 0.00 |
Cipla Ltd. | Pharmaceuticals | 5254.1 | 6.48% | 0.39% | 6.48% (Sep 2025) | 5.32% (Dec 2024) | 34.95 L | 2.95 L |
Apollo Hospitals Enterprises Ltd. | Hospital | 4806.9 | 5.92% | 0.01% | 5.92% (Sep 2025) | 5.13% (Nov 2024) | 6.49 L | 0.00 |
Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 4792.1 | 5.91% | 0.01% | 5.91% (Sep 2025) | 5.1% (Nov 2024) | 39.16 L | 0.00 |
Vijaya Diagnostic Centre Ltd. | Healthcare service provider | 2886.7 | 3.56% | 0.08% | 4.09% (Nov 2024) | 3.24% (May 2025) | 28.87 L | 0.00 |
Medplus Health Services Ltd. | Pharmacy retail | 2747.5 | 3.39% | -0.26% | 4.2% (May 2025) | 2.36% (Oct 2024) | 36.27 L | 0.00 |
Gland Pharma Ltd. | Pharmaceuticals | 2630 | 3.24% | 0.28% | 3.27% (Jun 2025) | 2.59% (Apr 2025) | 13.21 L | 0.00 |
GlaxoSmithKline Pharmaceuticals Ltd. | Pharmaceuticals | 2428.9 | 2.99% | -0.05% | 3.73% (May 2025) | 2.02% (Jan 2025) | 9.13 L | 0.00 |
Name | Type of Instrument | Weight (%) |
---|---|---|
TREPS | TREPS | 0.46% |
Net Receivables | Net Receivables | 0.10% |
Margin | Margin | 0.00% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 1.65 | 22.25 | 82.28 | 40.99 | 41.25 |
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | -0.88 | 7.21 | 24.91 | 23.74 | 18.78 |
Nippon India Japan Equity Fund - Growth | NA | 289.73 | 0.85 | 12.47 | 19.20 | 18.54 | 19.56 |
DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 3.58 | 3.70 | 10.13 | 15.38 | 0.00 |
HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | -0.65 | 11.79 | 31.46 | 15.38 | 0.00 |
SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 3.42 | 4.22 | 10.95 | 15.32 | 19.81 |
Franklin Asian Equity Fund - Growth | NA | 279.13 | 1.54 | 9.39 | 25.57 | 14.73 | 16.19 |
Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1984.52 | -0.73 | 3.35 | 12.64 | 14.24 | 0.00 |
ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 5.16 | 4.01 | 7.82 | 13.99 | 14.64 |
Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 2.68 | 2.39 | 20.50 | 12.62 | 0.00 |
Out of 130 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 9 is/are ranked 4 * , 14 is/are ranked 3 * , 7 is/are ranked 2 * , 3 is/are ranked 1 * , and 95 schemes are not ranked. See more about AMC
Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
---|---|---|---|---|---|---|---|
Nippon India Small Cap Fund - Growth | 4 | 66136.11 | -1.49 | -2.39 | 10.36 | -6.06 | 22.79 |
Nippon India ETF Nifty 50 BeES | 4 | 50743.44 | 2.06 | 3.78 | 9.28 | 5.24 | 14.99 |
Nippon India ETF Nifty 50 BeES | 4 | 50743.44 | 2.06 | 3.78 | 9.28 | 5.24 | 14.99 |
Nippon India Multicap Fund - Growth | 4 | 47294.47 | -0.62 | 1.19 | 11.67 | 0.83 | 22.84 |
Nippon India Large Cap Fund - Growth | 5 | 46463.11 | 0.44 | 3.69 | 10.97 | 5.08 | 20.15 |
Nippon India Growth Mid Cap Fund - Growth | 4 | 39328.98 | 0.13 | 1.76 | 12.91 | 1.37 | 25.50 |
CPSE ETF | NA | 32226.16 | 1.13 | 1.33 | 6.21 | -2.81 | 36.51 |
CPSE ETF | NA | 32226.16 | 1.13 | 1.36 | 6.28 | -2.74 | 36.80 |
Nippon India ETF Gold BeES | NA | 29322.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Nippon India ETF Gold BeES | NA | 29322.94 | 15.66 | 28.99 | 32.98 | 61.50 | 34.66 |